MapLight Therapeutics, Inc.
(MPLT - NASDAQ)
13,77 USD
📋 Profilo Aziendale

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders.

|